127 related articles for article (PubMed ID: 37587685)
1. Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database.
Watanabe Y; Tanaka A; Furuhashi K; Maruyama S
Ther Apher Dial; 2023 Dec; 27(6):1000-1009. PubMed ID: 37587685
[TBL] [Abstract][Full Text] [Related]
2. Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease.
Kamimura M; Matsuo M; Miyahara T; Kimura K; Matsumoto K; Nakaya T; Abe T; Akizawa T
Ther Apher; 2002 Dec; 6(6):467-70. PubMed ID: 12460413
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.
Tamura K; Tsurumi-Ikeya Y; Wakui H; Maeda A; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Haku S; Azuma K; Mitsuhashi H; Tamura N; Toya Y; Tokita Y; Kokuho T; Umemura S
Ther Apher Dial; 2013 Apr; 17(2):185-92. PubMed ID: 23551675
[TBL] [Abstract][Full Text] [Related]
4. Combination treatment using percutaneous transluminal angioplasty and low-density lipoprotein apheresis in a patient with peripheral arterial disease and a history of chronic hemodialysis.
Nishimura H; Enokida H; Tsuruta M; Yoshino Y; Yamada Y; Sugita S; Hayashi S; Arata K; Hayami H; Nishiyama K; Nakagawa M
J Clin Apher; 2013 Aug; 28(4):330-4. PubMed ID: 23450792
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Ushiyama C; Osada S; Inoue T; Shimada N; Koide H
J Diabetes Complications; 2003; 17(6):349-54. PubMed ID: 14583180
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results.
Weiss N; Julius U
Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):39-44. PubMed ID: 30875001
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Artery Disease: Its Adverse Consequences With and Without CKD.
Bourrier M; Ferguson TW; Embil JM; Rigatto C; Komenda P; Tangri N
Am J Kidney Dis; 2020 May; 75(5):705-712. PubMed ID: 31879218
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein apheresis for haemodialysis patients with peripheral arterial disease reduces reactive oxygen species production via suppression of NADPH oxidase gene expression in leucocytes.
Hara T; Kiyomoto H; Hitomi H; Moriwaki K; Ihara G; Kaifu K; Fujita Y; Higashiyama C; Nishiyama A; Kohno M
Nephrol Dial Transplant; 2009 Dec; 24(12):3818-25. PubMed ID: 19617260
[TBL] [Abstract][Full Text] [Related]
9. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
[TBL] [Abstract][Full Text] [Related]
10. CKD and Acute and Long-Term Outcome of Patients with Peripheral Artery Disease and Critical Limb Ischemia.
Lüders F; Bunzemeier H; Engelbertz C; Malyar NM; Meyborg M; Roeder N; Berger K; Reinecke H
Clin J Am Soc Nephrol; 2016 Feb; 11(2):216-22. PubMed ID: 26668023
[TBL] [Abstract][Full Text] [Related]
11. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
12. Improvement of bilateral lower-limb muscle oxygenation by low-density lipoprotein apheresis in a patient with peripheral artery disease undergoing hemodialysis.
Ito K; Ookawara S; Ueda Y; Hayasaka H; Kofuji M; Uchida T; Matsumoto H; Yamaguchi A; Morishita Y
Nefrologia (Engl Ed); 2019; 39(1):90-92. PubMed ID: 29422296
[No Abstract] [Full Text] [Related]
13. Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease.
Endo M; Kumakura H; Kanai H; Araki Y; Kasama S; Sumino H; Ichikawa S; Kurabayashi M
Hypertens Res; 2010 Sep; 33(9):911-5. PubMed ID: 20535117
[TBL] [Abstract][Full Text] [Related]
14. LDL apheresis in atherosclerotic disease with hyperlipidemia.
Naganuma S; Agishi T; Ota K
ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
16. Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study.
Nakajima F; Morimoto S; Yurugi T; Amari Y; Kasuno Y; Fukui M; Furumatsu Y; Kitamura T
Int J Artif Organs; 2012 Nov; 35(11):981-5. PubMed ID: 23065872
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effect of Endovascular Therapy and Low-Density Lipoprotein Apheresis Combined Treatment in Hemodialysis Patients With Critical Limb Ischemia due to Below-Knee Arterial Lesions.
Ohtake T; Mochida Y; Matsumi J; Tobita K; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Saito S; Kobayashi S
Ther Apher Dial; 2016 Dec; 20(6):661-667. PubMed ID: 27412946
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis.
Ho CLB; Chih HJ; Garimella PS; Matsushita K; Jansen S; Reid CM
Nephrology (Carlton); 2021 Oct; 26(10):798-808. PubMed ID: 34156137
[TBL] [Abstract][Full Text] [Related]
20. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.
Garimella PS; Hirsch AT
Adv Chronic Kidney Dis; 2014 Nov; 21(6):460-71. PubMed ID: 25443571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
